rxstat › Shortages › group 0162988

group 0162988 (Retevmo) shortage status

Shortage anticipated

Source: Health Canada shortage reports · Updated Jul 17, 2026

A shortage of group 0162988 is anticipated but not yet confirmed. 2 product(s) have anticipated-shortage reports on file with Health Canada.

Products affected

0 / 2

Reports on file

Shortage history

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Anticipated

RETEVMO

80MG · CAPSULE · ELI LILLY CANADA INC

DIN 02516926

Anticipated

RETEVMO

40MG · CAPSULE · ELI LILLY CANADA INC

DIN 02516918

Resolved

RETEVMO

80MG · CAPSULE · LOXO ONCOLOGY INC

DIN 02516926 · ended May 23, 2023 · Delay in shipping of the drug.

What's happening

A manufacturer has told Health Canada it expects supply of group 0162988 to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.

Recent changes

Jul 17, 2026 New report filed
Jul 17, 2026 New report filed

Common questions

When will group 0162988 be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is group 0162988 in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Capmatinib (Tabrecta) No current shortage Larotrectinib (Vitrakvi) No current shortage Dasatinib (Sprycel) Partial shortage 1 of 14 reported products affected Everolimus (Afinitor) Partial shortage 1 of 11 reported products affected Gefitinib Partial shortage 1 of 4 reported products affected · est. return Dec 31, 2026 Sunitinib (Sutent) Partial shortage 1 of 9 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.